Two Seas Capital Opposes CoreWeave's $9 Billion Stock Deal Over Undervaluation Concerns
-
最新报道：Two Seas Capital, Core Scientific's largest shareholder, opposes the $9 billion all-stock acquisition by CoreWeave, claiming it undervalues the company and exposes shareholders to undue risk. While recognizing CoreWeave's strategic benefits, Two Seas insists the deal must better reflect Core Scientific's AI infrastructure assets and growth potential. The firm plans to rally shareholder opposition, potentially sparking a proxy battle over equity-only transactions in volatile markets. Core Scientific, which recently exited bankruptcy as an energy-efficient AI infrastructure provider, faces criticism from Two Seas that its assets remain underpriced in the proposed merger.
下一篇
OpenArt Debates Ethical Challenges Amid $20M Revenue Surge
- OpenArt, an AI startup founded by ex-Google employees in 2022, has introduced a "one-click...
24小时热点
热点专题
414681